Literature DB >> 6139161

Cytotoxic T lymphocytes in DBA/2 mice harboring L5178Y cells in a tumor-dormant state.

M A Marsili, M K Robinson, G A Truitt, E F Wheelock.   

Abstract

Previous experiments have demonstrated a temporal relationship between the decline of cytotoxic T lymphocyte (CTL) activity in the peritoneal cavity of DBA/2 mice harboring L5178Y cells in a tumor-dormant state and the appearance of ascitic tumors. Some tumor-dormant mice remain clinically normal for many weeks after the decline of CTL activity, and this activity can be rapidly restimulated by an IP inoculation of irradiated L5178Y cells. We report here that the peritoneal cells from many tumor-dormant mice can be stimulated to cytolytic activity in vitro when cultured for 4 days either with or without the addition of irradiated L5178Y cells. Peritoneal cell populations which cannot be stimulated in vitro can suppress the generation of CTL in those populations which can be stimulated. The tumor-dormant state may terminate when suppressor cells in the peritoneal cavity of tumor-dormant mice inhibit the generation of CTL activity and permit tumor cells to produce an ascitic tumor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139161     DOI: 10.1007/bf00199907

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.

Authors:  K J Weinhold; E F Wheelock
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

2.  Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy.

Authors:  M A Marsili; M K Robinson; G A Truitt; E F Wheelock
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

3.  Identification of macrophage-mediated cytolytic activity as a tumor suppressive mechanism during maintenance of the L5178Y-tumor dormant state in DBA/2 mice.

Authors:  M K Robinson; E F Wheelock
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

4.  Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.

Authors:  H Kirchner; A V Muchmore; T M Chused; H T Holden; R B Herberman
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

5.  Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.

Authors:  A E Eggers; J R Wunderlich
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

6.  Expression of H-2 and Moloney leukemia virus-determined cell-surface antigens in synchronized cultures of a mouse cell line.

Authors:  M Cikes; S Friberg
Journal:  Proc Natl Acad Sci U S A       Date:  1971-03       Impact factor: 11.205

7.  The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice.

Authors:  K J Weinhold; L T Goldstein; E F Wheelock
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

8.  The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination.

Authors:  K J Weinhold; D A Miller; E F Wheelock
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

9.  Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice.

Authors:  N Minato; B R Bloom; C Jones; J Holland; L M Reid
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

10.  Generation of cytotoxic T lymphocytes in vitro. II. Effect of repeated exposure to alloantigens on the cytotoxic activity of long-term mixed leukocyte cultures.

Authors:  H R Macdonald; H D Engers; J C Cerottini; K T Brunner
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  1 in total

1.  Immune regulation of the L5178Y murine tumor-dormant state. I. In vivo and in vitro effects of prostaglandin E2 and indomethacin on tumor cell growth.

Authors:  C M Liu; T Okayasu; P Goldman; Y Suzuki; K Suzuki; E F Wheelock
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.